Kollaborationen und Projekte 


  • SaxoCHiLD is a designated partner of the future German Center for Child and Youth Health (DZKJ)

  • NORMAN Association is a self-sustaining network of reference laboratories, research centers and related organizations for the monitoring and biomonitoring of emerging environmental substances.

  • Beate Escher is honorary professor at the University of Queensland with main collaboration through the Queensland Alliance for Environmental Health Sciences Prof. Beate Escher at The University Of Queensland


We provide bioanalytical expertise with our facility CITEPro.

Aktuelle Drittmittelprojekte

  • QTOX We are members of the Doctoral Network QTOX Quantitative Extrapolation in Ecotoxicology (EU-funded project). QTOX will develop mechanistic knowledge and data-efficient modelling tools to bridge the gap between standard toxicity data and ecologically relevant endpoints arising from chronic, time variable exposures to chemical mixtures. The results will be achieved through an interdisciplinary and intersectoral research and training program in which 10 doctoral candidates will characterise the mechanistic processes describing the successive events from exposure to ecosystem-level effects and develop models for extrapolation of adverse effects across levels of biological organization under environmentally realistic conditions. Our contribution is in In-vitro to in-vivo extrapolations in ecotoxicology.
  • PANORAMIX This European Union funded project’s goal is to provide new tools for risk assessment of complex real-life mixtures. It focuses on substances present in water, food and the human body. Eleven European partners work together to develop a novel scientific framework to understand and quantify the risk of chemical mixture exposure and thus provide a basis for new regulations to better protect human health and the environment.
  • PrecisionTox The objective of this European Union funded project is to improve chemical safety assessment by replacing animal testing with non-traditional test species, determine safe levels of exposure and collaborate with regulators and other stakeholders to incorporate Precision Toxicology in policy and law.

  • NC3R CRACK IT challenge 36: Animal-free in vitro The Phase 2 of the Crack IT challenge is combining scientific, commercial and regulatory expertise. This 3 year project sponsored by AstraZeneca and Unilever aims to develop animal product-free adaptations of the in vitro OECD test guidelines TG487 and TG455 to improve human-relevant responses and reproducibility. The interdisciplinary consortium is led by ImmuOne, a British biotech company, and comprises, in addition to the UFZ, partners such as PAN Biotech, the University of Oxford and Goethe University Frankfurt. Our role in the project is the characterization and validation of the metabolic activity of the S9 alternative and the participation in the interlaboratory validation.

  • Effect-based Monitoring in Water Safety Planning in collaboration with the Global Water Research Coalition

Aktuelle Projekte innerhalb des UFZ

Abgeschlossene Projekte